Intranasal recombinant protein subunit vaccine targeting TLR3 induces respiratory tract IgA and CD8 T cell responses and protects against respiratory virus infection. - Wørzner K; Schmidt ST; Zimmermann J; Tami A; Polacek C; Fernandez-Antunez C; Hartmann KT; Jensen RF; Hansen JS; Illigen K; Isling LK; Erbs G; et al. (EBioMedicine, 2025)